Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3 EUR | -1.64% | -5.36% | -35.76% |
03-18 | Biotalys, Novonesis Sign Deal to Advance Biofungicide Candidate Development | MT |
03-18 | Biotalys and Novonesis Announces Manufacturing and Commercialization Partnership for EVOCA NG | CI |
Business Summary
Number of employees: 75
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kevin R. Helash
CEO | Chief Executive Officer | 59 | 11-30 |
Douglas Minder
DFI | Director of Finance/CFO | - | 31/12/20 |
Carlo Boutton
CTO | Chief Tech/Sci/R&D Officer | - | 02/05/22 |
Toon Musschoot
IRC | Investor Relations Contact | - | - |
Sophie Snijders
HRO | Human Resources Officer | - | 11-28 |
Eva van Hende
PRN | Corporate Officer/Principal | - | 11-28 |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 62 | 31/12/12 | |
Simon Moroney
CHM | Chairman | 65 | 31/03/21 |
Johan Cardoen
BRD | Director/Board Member | 65 | 31/12/12 |
Director/Board Member | 56 | 31/12/18 | |
Director/Board Member | 64 | 31/12/20 | |
Markus Heldt
BRD | Director/Board Member | 66 | 30/06/21 |
Director/Board Member | 64 | 31/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 32,157,210 | 17,610,966 ( 54.77 %) | 0 | 54.77 % |
Company contact information
Sector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.76% | 103M | |
+0.02% | 7.34B | |
+7.85% | 3.17B | |
+9.03% | 843M | |
-3.78% | 357M | |
+14.12% | 296M |
- Stock Market
- Equities
- BTLS Stock
- Company Biotalys NV